The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. Multiple strategies have been employed maximize antibody titer, such as process parameter optimization, cell line development, and implementation of perfusion processes. Fine-tuning culture conditio